Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility trial of effects of Parkinson's medications on memory
2012-000801-64Phase 4Terminated
- Sponsor
- Royal Stoke University Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pramipexole and ropinirole in Parkinson's disease (PD), sponsored by Royal Stoke University Hospital. Primary endpoint: Feasibility and acceptability outcomes. Started Nov 2012; status: terminated.
02
Drugs
pramipexoleropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2012-000801-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000801-64.